| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-02-25 | SGN-CD19B | non-Hodgkin lymphoma, DLBCL, diffuse large B-cell lymphoma, grade 3 follicular lymphoma | 1 | Seattle Genetics (USA - WA) | Cancer - Oncology |
| 2016-02-25 | MGN1703 (lefitolimod) | colorectal cancer | 3 | Mologen (Germany) | Cancer - Oncology |
| 2016-02-25 | Viaskin® Peanut | peanut allergy | 1b | DBV Technologies (France) | Allergic diseases - Immunological diseases |
| 2016-02-24 | mogamulizumab (KW-0761) and nivolumab | solid tumors | 1-2 | BMS (USA - NY) Kyowa Hakko Kirin Pharma (Japan) | Cancer - Oncology |
| 2016-02-24 | GS-9620 and GS-986 | HIV eradication strategy | preclinical | Gilead Sciences (USA - CA) | Infectious diseases |
| 2016-02-24 | cabotegravir | HIV prevention | 2 | ViiV Healthcare (UK - USA) | Infectious diseases |
| 2016-02-23 | MOD-5014 (Factor VIIa-CTP) | hemophilia A, hemophilia B | 1-2 | Opko Health (USA - Fl) | Rare diseases - Genetic diseases - Hematological diseases |
| 2016-02-23 | Tresiba® (insulin degludec) | type 1 and type 2 diabetes | 3 | Novo Nordisk (Denmark) | Metabolic diseases |
| 2016-02-23 | cabotegravir and rilpivirine | Infection, Human Immunodeficiency Virus | 2 | ViiV Healthcare (UK - USA) GSK (UK), Janssen Pharmaceuticals, a J&J company (USA - NJ) | Infectious diseases |
| 2016-02-22 | romosozumab (CDP7851/AMG 785) | postmenopausal women with osteoporosis | 3a | Amgen (USA - CA) UCB (Belgium) | Bone diseases |
| 2016-02-22 | TYG100 | pancreatic cancer | preclinical | OncoQR ML (Austria) TYG Oncology (UK) | Cancer - Oncology |
| 2016-02-19 | BPZE1 Pertussis Vaccine | Bordetella pertussis infection | 1b | ILiAD Biotechnologies (USA - NY) | Infectious diseases |
| 2016-02-19 | naldemedine | opioid-induced constipation (OIC) | 3 | Shionogi (Japan) | Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
| 2016-02-19 | ETS6103 | major depressive disorder | 2b | e-Therapeutics (UK) | CNS diseases - Mental diseases |
| 2016-02-17 | Xiapex®(EU)/ Xiaflex® (USA) collagenase clostridium histolyticum | edematous fibrosclerotic panniculopathy, commonly known as cellulite | 2b | Endo International (USA - PA) | Inflammatory diseases |
| 2016-02-16 | CyclASol (Cyclosporin solution) | dry eye syndrome | 2 | Novaliq (Germany) | Ophtalmological diseases |
| 2016-02-16 | GLPG1837 | cystic fibrosis with the S1251N mutation | 2 | Galapagos (Belgium) | Rare diseases - Genetic diseases |
| 2016-02-16 | Kevetrin® (thioureidobutyronitrile) | solid tumors | 1 | Cellceutix (USA - MA) | Cancer - Oncology |
| 2016-02-16 | roxadustat | anemia associated with chronic kidney disease (CKD) | 2 | FibroGen (USA - CA) | Kidney diseases - Renal diseases |
| 2016-02-16 | Diamyd® combined with one or several GABA-related substances | Diamyd Medical (Sweden) |
